FDA rejects Regenxbio’s rare-disease gene therapy - statnews.com
Source:STAT
The Food and Drug Administration has rejected a rare-disease gene therapy from Regenxbio, the company said Monday.
Related Articles
ChatGPT rolls out ads - TechCrunch
OpenAI faced a backlash late last year when it tested app suggestions that looked like unwanted ads. …
Josh D’Amaro Named Next Chief Executive Officer of Disney - thewaltdisneycompany.com
Effective March 18, Josh D’Amaro will become Chief Executive Officer of The Walt Disney Company, and …
Recent Trump investments reignite concerns around potential conflicts of interest - CNN
President Donald Trump purchased up to $2 million in Netflix and Warner Bros. Discovery investments …
Builders Push ‘Trump Homes’ to Win Backing for a Million Houses - Bloomberg
Builders are working on a plan for a massive program to develop “Trump Homes” that would address the …